Irritable bowel syndrome: New recommendations for diagnosis and treatment [4]

Archives of Internal Medicine

Volumn 163, Issue 11, 2003, Pages 1374-1375

  Lacy, Brian E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BULKING AGENT; CHLORIDE; LOPERAMIDE; SPASMOLYTIC AGENT; TEGASEROD;

ALGORITHM; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; EVIDENCE BASED MEDICINE; HUMAN; IRRITABLE COLON; LETTER; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW;

EID: 0037672923     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.11.1374-d     Document Type: Letter

References (5)

1. Fass R, Longstreth GF, Pimentel M. Evidence and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med. 2001; 161:2081-2088.
2. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 suppl):S1-S5.
3. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 suppl):S7-S26.
4. American Gastroenterological Association. AGA medical position statement: irritable bowel syndrome. Gastroenterology. 2002;123:2105-2107.
5. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-2131.